Dynamic RESEARCH PARTNERSHIPS

President Kimberly R. Cline. “Our ongoing partnership with Dassault Systèmes offers our faculty and students unprecedented opportunities to participate in this significant research to find new treatments for a myriad of major health issues.”

The University’s growing portfolio of highimpact investigations, world-renowned faculty and dynamic partnerships are helping to shape the future of health care and life sciences.

According to Dr. Mohammed Cherkaoui, LIU’s Vice President of Research, “Virtual twins enable researchers to accelerate the development and testing of new therapies, devices and medications. Our Center of Excellence will serve as a research hub of this project—which ultimately enables more cost-effective, faster and safer development and delivery of public health care solutions.”

“Technological advancements such as clinical trial decentralization and the creation of virtual twins are transforming research and development, enabling unprecedented data-driven collaboration between all stakeholders, regardless of where they are,” said Rama Kondru, co-CEO of Dassault Systèmes Medidata and the executive sponsor of the LIU Center of Excellence in Life Sciences.

In addition to touring the 3DEXPERIENCE Demo Center and COE laboratory, participants were able to learn the latest information about the use of virtual patients and regulatory science, hearing the least from the FDA on the use of simulation for in silico clinical trials, learn best practices from members of the Living Heart, Brain, Lung and Liver Projects and directly contribute to the development of the virtual human twin.

BUILDING BRIDGES: FIRST-EVER BIOBRIDGE INTERNATIONAL SCIENTIFIC CONFERENCE HELD IN BROOKLYN

ong Island University hosted the first-ever Biobridge International Scientific Conference in the country. The event was held on the LIU Brooklyn campus.

The Biobridge conference focused on the latest research and advances made in regenerative medicine and brought together more than 500 world-class physicians and researchers focusing on orthopedics and sports medicine, skincare and women’s health and prophylactic treatment to prevent postoperative infections.

The event highlighted collaborative research frameworks between Long Island University and RegenLab in the areas of medical devices, precision medicine, regenerative medicine and the development of innovative therapies. LIU and RegenLab’s alliance will advance and accelerate the research priorities of LIU’s Center of Excellence in Life Sciences, recently launched by Dassault Systèmes to address the next challenges in health care.

“As the first conference of its kind in the country, this event brought many renowned research and medical professionals together to highlight the progress made in the field of regenerative medicine,” said Long Island University President Kimberly R. Cline. “We were honored to welcome this global gathering of researchers and physicians to our campus, keeping with our commitment to serve as a higher education leader in life science and health care research.”

Long Island University is in the top 7% of research institutions in the United States as designated by the Carnegie Classification. The University’s growing portfolio of high-impact investigations, world-renowned faculty and dynamic partnerships are helping to shape the future of health care and life sciences.

According to Dr. Mohammed Cherkaoui, LIU’s Vice President of Research, “Our ongoing partnership with Dassault Systèmes, as well as hosting events such as this preeminent conference, position Long Island University as a major force in health care research and training. We are proud to play a leading role in finding new solutions for the world’s most pressing health issues as we teach a new generation of students to become innovators.”

Founded by RegenLab, the Biobridge Foundation has organized international scientific conferences in prestigious venues including the International Red Cross of Geneva and United Nations Organizations worldwide. Established in Switzerland in 2003, RegenLab has continuously been advancing the science and clinical practice of regenerative medicine and recently established its medical device production and administration facility inside the Brooklyn Army Terminal in New York.